Fred Upton

The superbug that doctors have been dreading just reached the U.S.

As my good friend and colleague Ms. DeGette said, through the GAIN Act of 2012 and the ADAPT Act, this committee has made a good number of strides to foster and encourage the development of new antibiotics that can fight the superbugs.

Well, thank you, Mr. Chairman. So today, we gather to discuss the U.S. public health response to antibiotic resistance...

The House Energy and Commerce Committee knows, better than I think just about any committee on the Hill, how important cybersecurity is.

We are holding this hearing to examine whether or not HHS has the opportunity, by embracing the reforms suggested in Mr. Long's and Ms. Matsui's bipartisan bill, not only to improve its own internal cybersecurity, but to become a leader in…

These reports show that, despite recent strides, CMS must stay vigilant to combat new and emerging threats to program integrity.

There was no input from patients or providers. In fact, this proposal threatens to disrupt many important Medicare models.

These tools are dramatic departures from how we approach prescription drugs access in this Nation and give the Federal Government far too much control over decisions that should be left between a doctor and their patient.

CMS would set payment rates for drugs they believe are therapeutically similar, despite which drug a patient needs.

There is bipartisan concern that this proposed Medicare drug experiment will threaten the care of our most vulnerable seniors in Michigan and throughout the country, and reduce access and availability of lifesaving drugs.

Today's hearing is an important exercise in Congressional oversight on a recently proposed rule from the Centers of Medicare and Medicaid Services (CMS) on Part B drugs.

There are no easy answers when it comes to head trauma. It may take time for research to provide the concrete answers the public demands but that is not an excuse for inaction.

House Republicans believe that no patient should be denied coverage or experience coverage shortages simply because they are sick.

We can strengthen health coverage by expanding plan offerings that allow for real choice--as well as incentivizing market innovation without mandates.

The health care system was turned upside down, promises were not kept, costs have gone up while quality has deteriorated.

Today's hearing is an important discussion on what Congress can do to help Americans across the country access better care at a lower cost.

Protecting our most vulnerable patients with preexisting condition safeguards is just as much about helping them keep health coverage.

We should strive to strike a balance between consumers having a marketplace of options to choose from to make sure their pet safely receives the care it needs, but doing so without breaking the bank.

The health and safety of the pets is a top priority for folks not only in Michigan, but around the country.

I want to be clear that just as our pets are part of our extended families, our vets are a trusted part, too, of that equation to keep them healthy and happy.

Congressman Latta's bill, the Advanced Nuclear Technology Development Act, will direct NRC to fulfill those obligations.

The proposed legislation for review this morning seeks to do just that.

Because of the large role nuclear energy plays in Michigan and across the country, it's imperative that folks have confidence in the Nuclear Regulatory Commission's mission to protect public health and safety.

With two nuclear power plants just miles from my home in Southwest Michigan, I know firsthand the importance of safe, clean nuclear energy to the nation's energy portfolio, as well as the economic benefits nuclear brings to local…

I hope this hearing helps the NIH and the FDA to undertake such reviews.